Overview

CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases

Status:
Not yet recruiting
Trial end date:
2027-01-15
Target enrollment:
Participant gender:
Summary
A Study of CD 70 CAR T for patients with CD70 positive malignant hematologic diseases
Phase:
Early Phase 1
Details
Lead Sponsor:
Zhejiang University
Collaborator:
Yake Biotechnology Ltd.